menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Strides Pharma gets USFDA nod to market HIV drug

    ECONOMIC TIMES

    Hagens Berman Sobol , Hilliard Announce a Class Action Antiretroviral Drugs

    PR NEWSWIRE

    Hetero Labs` Generic Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate Receives Approval in the U.S.

    FDA

    Laurus` Generic Efavirenz, Emtricitabine and Tenofovir Disoproxil FumarateReceives Approval in the U.S.

    FDA

    Macleods Pharms`s Generic Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate Receives Approval In US

    FDA

    Macleods Pharms`s Generic Efavirenz;Emtricitabine;Tenofovir Disoproxil Fumarate Receives Approval In US

    FDA

    Strides Pharma`s Generic Efavirenz Receives Approval In US

    FDA

    Antiretroviral Therapy`s +ve Impact On Global Public Health Faces Challenges

    FORBES

    PvPI study reveals major suspected ADRs in anti-retroviral drugs

    PHARMABIZ

    Cipla`s Generic Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Receives Approval In US

    FDA

    FDA Unveils 34 New and Revised Product-Specific Draft Guidances

    RAPS

    Indonesia seeks to reassure HIV patients over drug supplies

    REUTERS

    When medicine makes you sick: How tainted drugs can elude FDA inspections

    USA TODAY

    DOJ tells Supreme Court it has lost interest in its Gilead whistleblower case

    FIERCE PHARMA

    Teva Pharms` Generic Efavirenz; Emtricitabine; TDF Receives Approval in US

    FDA

    Teva Pharma`s Generic Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate Receives Approval in US

    FDA

    Aurobindo Pharma`s Generic Efavirenz; Emtricitabine; Tenofovir Disoproxil Fumarate Receives Approval in US

    FDA

    Merck`s virology business may not get that from 2 new HIV drugs

    BIOPHARMADIVE

    US approves MSD HIV drugs Delstrigo and Pifeltro

    PHARMA TIMES

    Is Gilead Poised for a Comeback?

    BIOSPACE

    Cipla climbs 3% on USFDA approval to HIV drug

    ECONOMIC TIMES

    Lupin launches generic antibiotic inhalation solution in US

    ECONOMIC TIMES

    Gilead Lawsuits: California HIV Patients File Class Action & Injury HIV Drug

    BUSINESSWIRE

    Hetero Labs III Generic Efavirenz Receives Approval In US

    FDA

    Strides Shasun`s Generic Efavirenz Receives Approval In US

    FDA

    KRKA, d.d., Novo mesto`s Efavirenz / Emtricitabine / Tenofovir Disoproxil Receives Approval In Europe

    EMA

    Mylan introduces generic Sustiva tablets in Us market to treat HIV

    PHARMABIZ

    Mylan Expands Access to HIV/AIDS Medicines with Launch of First Generic Sustiva®

    PR NEWSWIRE

    Rising Pharmaceuticals launches generic Sustiva

    DRUG STORE NEWS

    Aurobindo Pharma’s Generic Efavirenz Receives Approval In US

    FDA

    Seven medicines recommended for approval, including an advanced therapy

    EMA

    Mylan S.A.S`s Efavirenz/Emtricitabine/Tenofovir disoproxil Receives Approval In Europe

    EMA

    Zentiva k.s. Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva Receives Approval In Europe

    EMA

    FDA Confirms Paragraph IV Patent Challenge of Sustiva (Efavirenz) Capsules

    FDA

    Mylan Launches Three Generic Antiretrovial Medicines for HIV in Canada

    DDDMAG

    Gilead to launch injunction against Mylan & Actavis over HIV generics in Ireland

    PHARMAFILE

    Pharmacare’s Generic Efavirenz Receives Tentative Approval In US

    FDA

    Cipla’s Generic Efavirenz Receives Approval In US

    FDA

    Mylan Receives Tentative Approval for "TLE400" Under PEPFAR

    PR NEWSWIRE

    Pfizer faces first 2017 patent loss as Pristiq generics crash the party

    FIERCE PHARMA

    Gilead’s genvoya shows significantly higher rates of virologic suppression

    PHARMABIZ

    FDA calls for drug firms to declare costs

    BANGKOK POST

    More essential medicines to become cheaper with NPPA’s latest notification

    ECONOMIC TIMES

    Strides Shasun gets US health regulator tentative nod for HIV treatment drug

    ECONOMIC TIMES

    Indian Generic Manufacturer Cipla Targeting US HIV Market

    TWOFOUR INSIGHT

    Merck’s phase 3 study of once-daily Isentress in HIV-1 adults meet endpoints

    PHARMABIZ

    Mylan Labs Generic Efavirenz approved in US to treat HIV

    FDA

    Strides Shasun Receives Positive WHO Inspection Report for Formulation Facility

    TWOFOUR INSIGHT

    Bristol-Myers flips its HIV pipeline to GlaxoSmithKline`s ViiV in a $3B deal

    REUTERS

    Cipla ready to launch low dose HIV drug `Efavirenz`

    ECONOMIC TIMES

    ViiV Healthcare Attacking, but Gilead Prepares to Strike Back

    MOTLEY FOOL

    HIV Treatment Market Will See Slow Growth to 2023

    PHARMA EXEC

    Gilead`s low-dose, high-impact HIV drug heads to the FDA

    SAN FRANSISCO BUSINESS TIMES

    Which Pharma Needs Its Cash Cow Most? It`s Not Just About Numbers

    FIERCE PHARMA

    API Manufacturer Laurus Labs Believes in Excelling in its Chosen Segments, Not in Following Trends

    BUSINESS TODAY

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.